Charles River Laboratories | CRL - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Agilent USD 465M 11M 2026-03
Align Technology USD 465.34M 23.67M 2026-03
Bio-Rad Laboratories USD 221M 14.2M 2025-12
Bruker USD 242.1M 5.1M 2026-03
Cardinal Health USD 1.51B 6M 2026-03
Charles River Laboratories USD 159.42M 36.71M 2026-03
Cigna USD 3.32B 291M 2026-03
Concord Medical Services Hldg CNY 140.37M 36.24M 2025-06
Danaher USD 1.86B 166M 2026-03
Dentsply International USD 351M 32M 2026-03
Elevance Health USD 10.91B 309M 2025-12
Humana USD 3.36B 614M 2025-03
Illumina USD 272M 11M 2026-03
Incyte USD 328.1M 62.31M 2026-03
Intrexon USD 10.31M 41K 2024-06
IQVIA Holdings USD 502M 34M 2026-03
Laboratory Of America USD 551M 12.4M 2026-03
Lakefront Biotherapeutics EUR 35.5M 8.91M 2026-03
McKesson USD 1.8B 234M 2026-03
Merck EUR 1.52B 80M 2026-03
Mettler Toledo International USD 258.33M 1.5M 2026-03
Novartis USD 3.14B 296M 2026-03
Pfizer USD 2.92B 1.16B 2026-03
Quest Diagnostics USD 504M 0 2026-03
Revvity USD 253.88M 2.15M 2026-03
Thermo Fisher Scientific USD 1.8B 179M 2026-03
United Therapeutics USD 156.6M 34M 2026-03
UnitedHealth USD 15.22B 1.44B 2025-09
Veradigm USD 27.28M 5.24M 2022-12
Waters USD 394M 153.99M 2026-03
West Pharmaceutical Services USD 99.5M 7M 2026-03